After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $36.57B. A total of 2.62 million shares were traded on the day, compared to an average of 11.12M shares.
In the most recent transaction, Weiss Amir sold 12,300 shares of TEVA for 30.20 per share on Dec 16 ’25. After the transaction, the Chief Accounting Officer now owns 5,650 company shares. In a previous transaction on Dec 16 ’25, MIGNONE ROBERTO sold 77,400 shares at 30.24 per share. TEVA shares that Director owns now total 367,600.
Among the insiders who bought shares, Bridger Management, LLC (1) acquired of 150,000 shares on Dec 12 ’25 at a per-share price of $30.18. In another insider transaction, Daniell Richard sold 115,468 shares at $28.68 per share on Dec 09 ’25. Company shares held by the Exec. VP, European Commercial now total 48,384.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, TEVA has a high of $31.99 and a low of $12.47.
As of this writing, TEVA has an earnings estimate of $0.65 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.78 per share and a lower estimate of $0.58. The company reported an EPS of $0.71 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $6.32, while its Total Shareholder’s Equity was $11.24B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.83.
